TrialAnnals of oncology : official journal of the European Society for Medical Oncology2016

A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel.

K N Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.